申请人:SHIONOGI & CO., LTD.
公开号:EP2130820A1
公开(公告)日:2009-12-09
The present invention relates to the use of a compound having an agonistic activity to the cannabinoid receptor, a prodrug, a pharmaceutically acceptable salt or solvate thereof for the preparation of an antipruritic, wherein the compound having an agonistic activity to the cannabinoid receptor is a compound selected from
(R,S)-4,4,4-trifluoro-1-butane sulfonic acid-3-(2-hydroxymethyl-indanyl-4-oxy)-phenylester;
(S)-1-(4,4,4-trifluoro-1-butane sulfonic acid-3-(2-hydroxymethyl-indanyl-4-oxy)phenyl ester; and
(R)-1-(4,4,4-trifluoro-1-butane sulfonic acid-3-(2-hydroxymethyl-indanyl-4-oxy)phenyl ester.
本发明涉及一种对大麻素受体具有激动活性的化合物、其原药、药学上可接受的盐或溶液用于制备止痒剂的用途,其中对大麻素受体具有激动活性的化合物是选自以下各项的化合物
(R,S)-4,4,4-三氟-1-丁烷磺酸-3-(2-羟甲基-茚满-4-氧基)-苯酯;
(S)-1-(4,4,4-三氟-1-丁烷磺酸-3-(2-羟甲基-茚满-4-氧基)苯基酯;和
(R)-1-(4,4,4-三氟-1-丁烷磺酸-3-(2-羟甲基-茚满-4-氧基)苯基酯。